Zhiliang L. Gao
600 Tianhe Road
Guangzhou, 510630, China
Guangzhou, 510630, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 164 publications
Sorafenib enforces HIV-1 latency by selectively inhibiting PKC-driven STAT1/3 serine 727 phosphorylation.
Journal: Antimicrobial agents and chemotherapy
Published: August 03, 2026
APASL clinical practice guidelines on the management of chronic hepatitis B infection: a 2026 update
APASL clinical practice guidelines on the management of chronic hepatitis B infection: a 2026 update
Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
Published: July 27, 2026
Feasibility and cost-effectiveness of a hospital-based hepatitis B management model in China: the 'Hot Wave Project' experience.
Journal: Hepatology international
Published: December 18, 2025
APASL clinical practice guidelines on the management of chronic hepatitis B infection: a 2026 update.
Journal: Hepatology international
Published: December 13, 2025
Comparative effectiveness of tenofovir versus entecavir combined with peginterferon Alfa-2b for functional cure in HBeAg-negative chronic hepatitis B: a propensity score-matched analysis.
Journal: BMC infectious diseases
Published: November 05, 2025
Integrative network toxicology and experimental validation reveal novel molecular mediators of omeprazole-induced nephrotoxicity.
Journal: Toxicology and applied pharmacology
Published: October 14, 2025
Cross-cultural adaptation and validation of the postoperative recovery in children scale for dental treatment under general anesthesia (PRiC-DTGA) in Chinese children
Journal: Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology
Published: September 27, 2025
Metabolomic comparative study in patients with liver cirrhosis and hepatocellular carcinoma related to hepatitis B virus infection.
Journal: European journal of gastroenterology & hepatology
Published: August 13, 2025
Machine learning model for HBsAg seroclearance after 48-week pegylated interferon therapy in inactive HBsAg carriers: a retrospective study.
Journal: Virology journal
Published: August 03, 2025
Quantitatively Evaluate the Improvement of Functional Cure for the Quality of Life of Chronic Hepatitis B Cases: Evidence from a Cross-Sectional Study in China.
Journal: Healthcare (Basel, Switzerland)
Published: June 03, 2025
Correction: Nucleos(t)ide analogs continuation is not associated with a lower risk of HBsAg seroreversion following PEG-IFN-induced HBsAg loss.
Journal: Virology journal
Published: May 31, 2025
Last Updated: 09/26/2026